Skip to main content

Table 6 SSEE Analysis with Bootstrapped DerSimonian-Laird random-effects model calculated by STATA

From: Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis

STUDY

Overall

Subgroup: VHD

Subgroup: TAVI

Sensitivity Test

Harbord’s modified test

RR

95%CI

Weight(%)

RR

95%CI

Weight(%)

RR

95%CI

Weight(%)

RR

95%CI

p-value

ARISTOTLE, 2015

0.699

0.510, 0.959

23.77

0.699

0.510, 0.959

26.35

 

0.661

0.415, 1.054

0.97

ENGAGE AF-TIMI 48, 2017

0.838

0.595, 1.181

22.99

0.838

0.595, 1.181

25.42

0.622

0.412, 0.939

RE-LY, 2016

0.387

0.273, 0.548

22.85

0.387

0.273, 0.548

25.25

0.772

0.633, 0.941

ROCKET AF, 2014

0.81

0.536, 1.224

20.95

0.81

0.536, 1.224

22.99

0.633

0.417, 0.960

Seeger, 2017

0.398

0.105, 1.508

5.64

 

0.398

0.105, 1.508

54.56

0.685

0.479, 0.979

Geis, 2018

2.234

0.415, 12.026

3.8

2.234

0.415, 12.026

45.44

0.636

0.456, 0.886

Overall

0.665

0.468, 0.945

100

0.652

0.457, 0.930

100

0.872

0.159, 4.767

100

0.664

0.474, 0.931

Heterogeneity Measures

Value

df

p-value

Value

df

p-value

Value

df

p-value

  

Cochran’s Q

14.59

5

0.012

12.12

3

0.007

2.47

1

0.116

Heterogeneity Measures

Value (95%CI)

Value (95%CI)

Value (95%CI)

I2 (%)

62.7

9.41, 84.65

75.27

31.56, 91.07

60.52

0.00, 90.80

H2

2.68

1.10, 6.51

4.04

1.46, 11.19

2.53

0.59, 10.87

tau2 (BDL)

0.109

0.098

0.916